Download in electronic PDF format for $25



Search the Complete Journal Archives

Basics of Compounding: The "Negative" List

Author(s):  Allen Loyd V

Issue:  Jul/Aug 2015 - Volume 19, Number 4
View All Articles in Issue

Abstract:  H.R. 3204 requires the formation of a Pharmacy Compounding Advisory Committee to address the following: The “Negative List”; The “Positive List of Active Pharmaceutical Ingredients”; and “Demonstrable Difficulties in Compounding.” At the first meeting of the Pharmacy Compounding Advisory Committee, the Committee addressed the drug products that have been withdrawn or removed from the market and cannot be compounded because they have been found to be unsafe or not effective. This article provides a current list of drugs that cannot be used in compounding, as well as a “kit” where the combination of ingredients/products cannot be compounded.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, do not compound list, U.S. Food and Drug Administration, FDA, Drug Quality and Security Act, Pharmacy Compounding Advisory Committee, drug safety

Related Categories: LEGAL, DISCONTINUED FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr Sep/Oct 2015 389-390 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Standing Together Fixing the Drug Quality and Security Act Miller David G Mar/Apr 2015 104-106 Buy
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Nov/Dec 2016 457-458 Buy
Basics of Compounding: The "Negative" List Allen Loyd V Jul/Aug 2015 311-313 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181 Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E Sep/Oct 2014 379-380 Buy
The "Lists": What Do They Mean? Voliva John Nov/Dec 2016 477-479 Buy